SuperworthAurinia Pharmaceuticals market cap AUPH
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $2.2B
- Highest close in our data
- $4.2B
- Oct 2021
Aurinia Pharmaceuticals is worth $2.2B at the close on Oct 23, 2026, at $16.86 a share.
That is up 43% over the last year and down 47% over five years.
Its highest close in our data was $4.2B in Oct 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.2B | $1.9B | $2.2B | +5% |
| 2025 | $2.1B | $1B | $2.1B | +63% |
| 2024 | $1.3B | $710.1M | $1.3B | +2% |
| 2023 | $1.3B | $1B | $1.8B | +110% |
| 2022 | $613.9M | $613.9M | $2.6B | −79% |
| 2021 | $3B | $1.3B | $4.2B | +92% |
| 2020 | $1.5B | $1.4B | $1.9B | −16% |
| 2019 | $1.8B | $351M | $1.8B | +219% |
| 2018 | $574.1M | $432.9M | $574.1M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Aurinia Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| AUPHAurinia Pharmaceuticals | $2.2B |
| PBHPrestige Consumer Healthcare | $2.3B |
| HRMYHarmony Biosciences | $2.1B |
| NRIXNurix Therapeutics | $2.8B |
| ANIPANI Pharmaceuticals | $1.7B |
| PAHCPhibro Animal Health | $1.6B |
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.8B |
| ARQTArcutis Biotherapeutics | $3.9B |
| Peer median | $2.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Aurinia Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.